医学
重症监护医学
输血
贫血
血红蛋白
血液替代品
氧气输送
氧气
红细胞
外科
免疫学
内科学
有机化学
化学
作者
Jonathan S. Jahr,Nicole R. Guinn,David R. Lowery,Linda Shore‐Lesserson,Aryeh Shander
标识
DOI:10.1213/ane.0000000000003957
摘要
Despite the exhaustive search for an acceptable substitute to erythrocyte transfusion, neither chemical-based products such as perfluorocarbons nor hemoglobin-based oxygen carriers have succeeded in providing a reasonable alternative to allogeneic blood transfusion. However, there remain scenarios in which blood transfusion is not an option, due to patient's religious beliefs, inability to find adequately cross-matched erythrocytes, or in remote locations. In these situations, artificial oxygen carriers may provide a mortality benefit for patients with severe, life-threatening anemia. This article provides an up-to-date review of the history and development, clinical trials, new technology, and current standing of artificial oxygen carriers as an alternative to transfusion when blood is not an option.
科研通智能强力驱动
Strongly Powered by AbleSci AI